Related Experiment Video
Updated: Feb 11, 2026
13:38
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.7K
Aspirin: the miracle drug?
1Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA. thotap@ccf.org.
Clinical and Translational Gastroenterology
|May 4, 2018
Summary
Regular aspirin use significantly lowers the risk of developing Barrett's esophagus in women. The protective effect of aspirin increases with higher frequency and longer duration of use.
Area of Science:
- Gastroenterology
- Oncology
- Epidemiology
Background:
- Barrett's esophagus is a precursor to esophageal adenocarcinoma.
- The role of aspirin in preventing Barrett's esophagus, particularly in women, is not well-established.
- Previous research on aspirin's preventive effects on Barrett's esophagus is limited, especially concerning female populations.
Discussion:
- This study investigated the association between aspirin use and the incidence of Barrett's esophagus in women.
- The research utilized data from the Nurses' Health Study to analyze aspirin consumption patterns and Barrett's esophagus diagnosis.
- Findings suggest a potential chemopreventive role for aspirin against Barrett's esophagus.
Key Insights:
- Women using aspirin showed a 27% reduced risk of developing Barrett's esophagus.
- The protective association between aspirin and Barrett's esophagus was dose-dependent, with increased risk reduction observed for higher frequency and longer duration of use.
- This study provides significant evidence supporting the lower prevalence of Barrett's esophagus among female aspirin users.
Outlook:
- Further research is warranted to elucidate the precise mechanisms underlying aspirin's protective effects.
- Investigating the optimal dosage and duration of aspirin for chemoprevention of Barrett's esophagus is crucial.
- Clinical trials could explore the efficacy of aspirin in preventing neoplastic progression in patients with Barrett's esophagus.
More Related Videos
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
462
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
462
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
163
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
163
01:26FDA Approved Drugs: Changes to Approved Drugs
273
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
273
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
262
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
262
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
490
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
490